Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) said it continues to expect 2013 revenue of approximately $55.0 million. The current consensus estimate is revenue of $50.8 million for the year ending December 31, 2013.
The exit from this might be slow, but I would not expect that the share price should rise on anything stated yesterday. Even if they get a breakeven year somehow, that never help the stock price for the past few years. You caught a fluke of a stock, hopefully you now realize it.